Co-Diagnostics Inventory 2017-2025 | CODX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Co-Diagnostics inventory from 2017 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Co-Diagnostics inventory from 2017 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$145.2B
CVS Health (CVS)	$74.3B
Elevance Health (ELV)	$63.1B
Cencora (COR)	$56.3B
DiDi Global (DIDIY)	$26.2B
Labcorp Holdings (LH)	$22.4B
Natera (NTRA)	$19.3B
BioMerieux (BMXMF)	$16B
ICON (ICLR)	$15.7B
EUROFINS SCIENT (ERFSF)	$14.8B
CochLear (CHEOY)	$13.4B
Medpace Holdings (MEDP)	$12.8B
Solventum (SOLV)	$12.8B
Revvity (RVTY)	$12B
Viatris (VTRS)	$11B
Avantor (AVTR)	$9.5B
Sonic Healthcare (SKHHY)	$9.3B
Charles River Laboratories (CRL)	$8.7B
HealthEquity (HQY)	$8.2B
Caris Life Sciences,�Inc (CAI)	$7.5B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.4B
Surgery Partners (SGRY)	$2.7B
Organon (OGN)	$2.6B
Concentras Parent (CON)	$2.5B
GeneDx Holdings (WGS)	$2.3B
Alignment Healthcare (ALHC)	$2.3B
Progyny (PGNY)	$2B